Analysis of anemia and iron supplementation among glioblastoma patients reveals sex-biased association between anemia and survival.
Analysis of anemia and iron supplementation among glioblastoma patients reveals sex-biased association between anemia and survival.
复制标题
胶质母细胞瘤患者贫血和补铁的分析揭示了贫血和生存之间的性别偏见。
DOI:
10.1038/s41598-024-52492-8
复制
发表时间:
2024-01-29
影响因子:
4.6
通讯作者:
中科院分区:
文献类型:
--
作者:
The association between anemia and outcomes in glioblastoma patients is unclear. We analyzed data from 1346 histologically confirmed adult glioblastoma patients in the TriNetX Research Network. Median hemoglobin and hematocrit levels were quantified for 6 months following diagnosis and used to classify patients as anemic or non-anemic. Associations of anemia and iron supplementation of anemic patients with median overall survival (median-OS) were then studied. Among 1346 glioblastoma patients, 35.9% of male and 40.5% of female patients were classified as anemic using hemoglobin-based WHO guidelines. Among males, anemia was associated with reduced median-OS compared to matched non-anemic males using hemoglobin (HR 1.24; 95% CI 1.00–1.53) or hematocrit-based cutoffs (HR 1.28; 95% CI 1.03–1.59). Among females, anemia was not associated with median-OS using hemoglobin (HR 1.00; 95% CI 0.78–1.27) or hematocrit-based cutoffs (HR: 1.10; 95% CI 0.85–1.41). Iron supplementation of anemic females trended toward increased median-OS (HR 0.61; 95% CI 0.32–1.19) although failing to reach statistical significance whereas no significant association was found in anemic males (HR 0.85; 95% CI 0.41–1.75). Functional transferrin-binding assays confirmed sexually dimorphic binding in resected patient samples indicating underlying differences in iron biology. Anemia among glioblastoma patients exhibits a sex-specific association with survival.
登录
查看更多内容
影响因子:
7.3
作者:
Bannoud N;Dalotto-Moreno T;Kindgard L;García PA;Blidner AG;Mariño KV;Rabinovich GA;Croci DO
通讯作者:
Croci DO
影响因子:
4.7
作者:
Guo Q;Li L;Hou S;Yuan Z;Li C;Zhang W;Zheng L;Li X
通讯作者:
Li X
影响因子:
7.3
作者:
Costa da Silva M;Breckwoldt MO;Vinchi F;Correia MP;Stojanovic A;Thielmann CM;Meister M;Muley T;Warth A;Platten M;Hentze MW;Cerwenka A;Muckenthaler MU
通讯作者:
Muckenthaler MU
DOI:
10.3390/ph11040094
发表时间:
2018-09-30
期刊:
Pharmaceuticals (Basel, Switzerland)
影响因子:
--
作者:
Busti F;Marchi G;Ugolini S;Castagna A;Girelli D
通讯作者:
Girelli D
影响因子:
5.6
作者:
Charriaut-Marlangue C;Besson VC;Baud O
通讯作者:
Baud O